Skip to main content
Clinical Trials/NCT05648773
NCT05648773CompletedNot Applicable

COVID-19 Booster Incentives in a County-Run Health System

University of Southern California1 site in 1 country57,893 target enrollmentStarted: December 8, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
57,893
Locations
1
Primary Endpoint
Vaccine booster

Study Overview

Brief Summary

The goal of this work is to understand whether small financial incentives and messaging can increase the take-up of COVID-19 boosters among patients empaneled at a county public health system. The motivation for this work is the relatively low take-up of COVID-19 boosters. In California, where our experiment is based, only 59% of the population has been boosted, with only 13% receiving the recommended bivalent booster (State of California, 2022).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age: 18 and above
  • •At least one COVID-19 vaccination (primary series or monovalent booster) but no vaccination dose within the past 2-months.
  • •Active phone number or email

Exclusion Criteria

  • •Opt-out of health system messaging

Arms & Interventions

Message Only

Experimental

Email or SMS Booster Vaccination Reminder

Intervention: Messaging (Behavioral)

Message + Financial Incentive

Experimental

Email or SMS Booster Vaccination Reminder + Offer of a financial incentive for getting boosted in the next 2 weeks.

Intervention: Messaging (Behavioral)

Message + Financial Incentive

Experimental

Email or SMS Booster Vaccination Reminder + Offer of a financial incentive for getting boosted in the next 2 weeks.

Intervention: Financial Incentive (Behavioral)

Control

Placebo Comparator

No message or financial incentive

Intervention: Placebo (Other)

Outcomes

Primary Outcomes

Vaccine booster

Time Frame: 2 weeks

Received a booster vaccination within 2-weeks of message.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mireille Jacobson

Associate Professor

University of Southern California

Study Sites (1)

Loading locations...

Similar Trials